Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00090
|
|||||
Drug Name |
UDP-xylose
|
|||||
Synonyms |
AC1L2DQI; CHEBI:16082; DB01713; GTPL4730; J-700264; Mono-a-D-xylopyranosyl ester; P1-a-D-xylopyranosyl ester; UDP-ALPHA-D-XYLOPYRANOSE; UDP-D-xylose; UDP-a-D-xylose; UDP-alpha-D-xylose; UDP-xylose; UDPxylose; UDX; URIDINE DIPHOSPHATE XYLOSE; URIDINE-5'-DIPHOSPHATE-XYLOPYRANOSE; Udp xylose; Uridine 5'-(trihydrogen diphosphate), P'-alpha-D-xylopyranosyl ester; Uridine 5'-diphosphoric acid beta-a; Uridine 51-pyrophosphate, a-D-xylopyranosyl ester; ZINC8551129; uridine 5'-[3-(alpha-D-xylopyranosyl) dihydrogen diphosphate]
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C14H22N2O16P2
|
|||||
Canonical SMILES |
C1C(C(C(C(O1)OP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)O)O)O
|
|||||
InChI |
InChI=1S/C14H22N2O16P2/c17-5-3-28-13(11(22)8(5)19)31-34(26,27)32-33(24,25)29-4-6-9(20)10(21)12(30-6)16-2-1-7(18)15-14(16)23/h1-2,5-6,8-13,17,19-22H,3-4H2,(H,24,25)(H,26,27)(H,15,18,23)/t5-,6-,8+,9-,10-,11-,12-,13-/m1/s1
|
|||||
InChIKey |
DQQDLYVHOTZLOR-OCIMBMBZSA-N
|
|||||
CAS Number |
CAS 3616-06-6
|
|||||
Pharmaceutical Properties | Molecular Weight | 536.28 | Topological Polar Surface Area | 271 | ||
Heavy Atom Count | 34 | Rotatable Bond Count | 8 | |||
Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 16 | |||
XLogP |
-6.6
|
|||||
PubChem CID | ||||||
PubChem SID | ||||||
ChEBI ID |
CHEBI:16082
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | SLC35B4 | Transporter Info | UDP-xylose and UDP-N-acetylglucosamine transporter | Substrate | [1] | |
References | ||||||
1 | The human solute carrier gene SLC35B4 encodes a bifunctional nucleotide sugar transporter with specificity for UDP-xylose and UDP-N-acetylglucosamine. J Biol Chem. 2005 Jul 22;280(29):27230-5. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.